0001062993-22-015670.txt : 20220630
0001062993-22-015670.hdr.sgml : 20220630
20220630160528
ACCESSION NUMBER: 0001062993-22-015670
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220607
FILED AS OF DATE: 20220630
DATE AS OF CHANGE: 20220630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dykan Jeff
CENTRAL INDEX KEY: 0001661229
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36612
FILM NUMBER: 221058064
MAIL ADDRESS:
STREET 1: KOCHAV YOKNEAM BUILDING, FLOOR 6
STREET 2: P.O. BOX 161
CITY: YOKNEAM ILIT
STATE: L3
ZIP: 20692
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ReWalk Robotics Ltd.
CENTRAL INDEX KEY: 0001607962
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 HATNUFA ST.
STREET 2: FLOOR 6
CITY: YOKNEAM ILIT
STATE: L3
ZIP: 2069203
BUSINESS PHONE: 97249590123
MAIL ADDRESS:
STREET 1: 3 HATNUFA ST.
STREET 2: FLOOR 6
CITY: YOKNEAM ILIT
STATE: L3
ZIP: 2069203
FORMER COMPANY:
FORMER CONFORMED NAME: Argo Medical Technologies Ltd.
DATE OF NAME CHANGE: 20140513
4/A
1
form4a.xml
AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4/A
2022-06-07
2022-06-09
0001607962
ReWalk Robotics Ltd.
RWLK
0001661229
Dykan Jeff
C/O REWALK ROBOTICS LTD.
3 HATNUFA ST., P.O. BOX 161
YOKNEAM ILIT L3
20692203
1
0
0
0
Ordinary Shares, par value NIS 0.25 per share
2022-06-07
4
P
0
15000
1
A
32162
D
Ordinary Shares, par value NIS 0.25 per share
2022-06-08
4
P
0
10000
1.04
A
42162
D
Ordinary Shares, par value NIS 0.25 per share
55874
I
By Partnership
This amendment is being filed to correct the number of shares directly and indirectly held by the reporting person. On July 7, 2020, the reporting person reported the acquisition of 10,948 Ordinary Shares underlying restricted stock units, which were granted to the reporting person on July 2, 2020 pursuant to the issuer's equity compensation plan. Such Ordinary Shares should have been reported as directly held, but due to an administrative error, such shares were mistakenly reported as indirectly held. See also footnote 6.
Represents Ordinary Shares purchased in the open market on June 7, 2022.
The range in prices for the transaction reported on this line was $1.00 to $1.01. The average weighted price was $1.00. The reporting person will provide, upon request by the Securities and Exchange Commission ("SEC"), the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within such range.
Represents Ordinary Shares purchased in the open market on June 8, 2022.
The range in prices for the transaction reported on this line was $1.03 to $1.04. The average weighted price was $1.04. The reporting person will provide, upon request by the SEC, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within such range.
Based on filings made with the SEC, consists of 40,707 Ordinary Shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 Ordinary Shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 55,874 shares of the Company.
/s/ Jeff Dykan
2022-06-30